Видео 18
Просмотров 17 823

Webinaire Risk of Bias 2 - Domaines 3 et 4

59:44

Webinaire Risk of Bias 2 - Domaines 1 et 2

1:07:29

Cochrane France : faciliter le transfert de connaissances

1:58

Qu'est-ce qu'une revue systématique ?

3:24

Transparency and clinical guidelines by Holger Schunemann

32:02

Transparency of Therapeutic Research - closing remarks by Jeremy Grimshaw

8:51

Webinaire Risk of Bias 2 - Domaine 5 et jugement global

Webinaire Risk of Bias 2 - Domaine 5 et jugement global

Видео

Webinaire Risk of Bias 2 - Domaines 3 et 4

59:44

Webinaire Risk of Bias 2 - Domaines 3 et 4

Просмотров 430Год назад

Webinaire Risk of Bias 2 - Domaines 3 et 4

Webinaire Risk of Bias 2 - Domaines 1 et 2

1:07:29

Webinaire Risk of Bias 2 - Domaines 1 et 2

Просмотров 933Год назад

Webinaire Risk of Bias 2 - Domaines 1 et 2

Cochrane France : faciliter le transfert de connaissances

1:58

Cochrane France : faciliter le transfert de connaissances

Просмотров 1454 года назад

Cette vidéo décrit le travail quotidien de l'équipe de Cochrane France pour améliorer le transfert de connaissances. Retrouvez notre site internet ici : france.cochrane.org/ Et les résumés Cochrane traduits en français : www.cochrane.org/fr/search/site/ Vous souhaitez vous engager avec Cochrane France ? france.cochrane.org/news/engagez-vous-avec-cochrane-france

3:24

Qu'est-ce qu'une revue systématique ?

Просмотров 15 тыс.5 лет назад

'Qu'est-ce qu'une revue systématique?' Si vous êtes un collaborateur de Cochrane et que vous avez déjà tenté d'expliquer le travail de Cochrane à quelqu'un, il y a de fortes chances que vous ayez essayé de répondre à cette question. Et si vous lisez ceci parce que vous ne connaissez pas ou peu Cochrane et notre travail, vous vous posez peut-être la même question. Grâce à une équipe de collègues...

Transparency and clinical guidelines by Holger Schunemann

32:02

Transparency and clinical guidelines by Holger Schunemann

Просмотров 3069 лет назад

Introduction: Content: - The solution-guidelines: a: Clinical Practice Guidelines b: A COPD guideline c: Another COPD guideline - Wich approach? - What to do? - Hierarchy of evidence based on quality Explain the following? a: Evidence: parachute randomised controlled risks - Simple hierarchies are (too) simlistic: a: A systematic review of randomized trials in cancer patients b: Do you have con...

Transparency of Therapeutic Research - closing remarks by Jeremy Grimshaw

8:51

Transparency of Therapeutic Research - closing remarks by Jeremy Grimshaw

Просмотров 459 лет назад

- Final Introductory Speech - The Cochrane Collaboration: A: Join Cochrane Colloquium in New-Zeland B: Join Cochrane Colloquium in Canada Merci!

Publishing raw data: Practical considerations by Doug Altman

27:04

Publishing raw data: Practical considerations by Doug Altman

Просмотров 2819 лет назад

- Intriductory Speech: I) Broad Concerns about bad publication practices: A: Taxonomy of poor reporting B: Some type of selective reporting in RCT's II) Some possible solutions: A: Sharing and archiving of data B: Publish or perish! C: Sharing raw data from randomized trials by A. Vidckers a: Appendix III) Why share data? A: Funder policies B Welcome Trust Policy Statement august 2010 C: Medica...

Access to data from regulatory authorities by Peter Gotzche

20:36

Access to data from regulatory authorities by Peter Gotzche

Просмотров 669 лет назад

- Introduction to case study and propose : a: EU legislative framework b: A reply from EMA's director c: Timeline. 3.5years d: EMA's Commercial interests e: The Ombudsman on commercial interests f: Over-reding public interest g: The Ombudsman on over-riding public interest h: Other arguments i: The Ombudman on personal data j: the European Ombydsman after a 3-year stand-off k: Implications - On...

The OPEN project: Overcoming failure to publish negative findings by Gerd Antes

19:18

The OPEN project: Overcoming failure to publish negative findings by Gerd Antes

Просмотров 1139 лет назад

- Introduction: a: Contents - Transfer of Research into Practice: a: Recognition of the problem in the literature (J Med Ethics, 2008) b: Publication (2007) after registration (1999) - Selective reporting: a: Is selective reporting harmful ? b: European Science Fondation Selective Publication c: Declaration of Helsinki: Executive Summary - Case Study 1: Tamiflu: a: About Tamiflu in the literatu...

Role of the Cochrane collaboration in the roadmap towards transparency by David Tovey

19:50

Role of the Cochrane collaboration in the roadmap towards transparency by David Tovey

Просмотров 469 лет назад

- Introduction A: Four words B: Agenda C: The Purpose: Trust and transparency in medicine D: Building blocks of good research E: The People: guiding principles - Reviews: A: Quality & transparency B: Infrastructure C: Support D: Quality expectations - Transparency in action: A: Plain language summaries B: Risk of bias tool C: GRADE and Summary of Findings Tables D: Transparent data - The Review...

A Cochrane review and its health policy implications by Sasha Shepperd

20:41

A Cochrane review and its health policy implications by Sasha Shepperd

Просмотров 739 лет назад

- Introduction: I) Defining concepts: A: Service delivery interventions B: Differences in Key concepts a: European Association for the Development of Palliative Care (EAPC) Task Force on the Development of Palliative Care in Europe C: Definitions of end-of-life care a: European Association of Palliative Care II) Cochrane Review: End of life care at home a: Review questions b: End of life care a...

The Example of Home Based End of the results on the FHS by Isabelle Colombet

21:44

The Example of Home Based End of the results on the FHS by Isabelle Colombet

Просмотров 589 лет назад

- Introductory speech I) Current challenges and methodological perspectives: A: Location of death (France, 1990, 2000, 2008) B: Who is more likely to die at home ? a: % Death at hospitals, by country, and by causes (2003) b: Proposition of deaths at hospital by region in France (2008) II) Palliative care in France: a political will: A: Organisation of palliative care in France a: Cross sectionn...

Closing rmarks: Patient safety and the EPOC group by Pierre Durieux

4:01

Closing rmarks: Patient safety and the EPOC group by Pierre Durieux

Просмотров 199 лет назад

- Current agenda: Professional intervention I) Challenges: lack of data on finicial and organizational intervention A: Example: End of life by Sasha Shepherd B: Organisational intervention C: Professional intervention D: Patient safety intervention II) Challenges: how to include qualitative research in Cochrane reviews? A) EPOC and CPD B) Epoc and studies published in journals C) Collaboration ...

Patient safety and research in France by Philippe Michel

27:43

Patient safety and research in France by Philippe Michel

Просмотров 359 лет назад

I) Introduction: The definition of Patient safety: A: Patient safety research is part of the "Improvement science" B: What is Patient safety Research? C: "Patient safety research" in France" a: Research organisation b: "La,dscape of institutions" II) Challenges in patient safety research: A: The "type of intervention" issue B: the " black box" issue in patient safety research C: 18 factors to p...